San Diego-based Arcturus Therapeutics Inc. today announced that Joseph Payne, President and Chief Executive Officer of Arcturus, will present at the Raymond James Human Health Innovation Conference. 

Founded in 2013, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines.

Arcturus' technologies are covered by its extensive patent portfolio with 187 patents and patent applications, issued in the U.S., Europe, Japan, China and other countries.

Over the years, Arcturus has had collaborations with Janssen Pharmaceuticals, Inc., Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, CureVac AG, Synthetic Genomics Inc., Duke-NUS, Catalent Inc., and the Cystic Fibrosis Foundation.

Date: Thursday, June 18

Time: 3:00 pm Eastern Time

Location: Virtual Track